NEXALIN TECHNOLOGY INC. - COMMON STOCK

Nexalin Technology Reports Significant Positive Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device on Treatment-Resistant Depression

18 12 2023 07:30:00 提供 Nasdaq GlobeNewswire

Nexalin Technology Announces Formation of New Military & Government Advisory Board to be Led by Government Affairs Veteran David Lasseter

25 10 2023 07:30:00 提供 Nasdaq GlobeNewswire

Nexalin Technology Announces Publication of Groundbreaking Deep-Brain Stimulation Study in Leading Peer-Reviewed Journal; Validates the Ability of Nexalin’s Neurostimulation Device to Penetrate Deep Brain Structures

16 10 2023 07:30:00 提供 Nasdaq GlobeNewswire

Nexalin Technology Reports Results of Clinical Study Supporting the Therapeutic Benefits of its Gen-2, 15 Milliamp Neurostimulation Device in Treating Migraine Headaches and Related Symptoms

07 8 2023 07:30:00 提供 Nasdaq GlobeNewswire

Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern Time

03 8 2023 07:30:00 提供 Nasdaq GlobeNewswire

Nexalin Technology Announces New Public Sector Division to Capitalize on Opportunities to Serve U.S. Government Agencies

26 7 2023 07:30:00 提供 Nasdaq GlobeNewswire

Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain Injury

10 7 2023 07:30:00 提供 Nasdaq GlobeNewswire

Nexalin Technology, Inc. and Wider Come Limited Announce Joint Venture Agreement to Advance Commercialization of Nexalin’s tACS Devices in the Asia Pacific Region

01 6 2023 07:30:00 提供 Nasdaq GlobeNewswire